Lyophilized vs Pasteurized Akkermansia: Which Probiotic Format Is Better?

Lyophilized vs Pasteurized Akkermansia: What the Evidence Actually Shows

Akkermansia muciniphila is one of the most talked-about gut bacteria in metabolic health, and as it has moved into supplements, a practical question keeps coming up: is it better taken live (freeze-dried, or lyophilized) or pasteurized (heat-treated)? It is a fair question, and the honest answer is more surprising than the marketing on either side suggests. Here is what the research actually shows, where it is still uncertain, and how to think about choosing.

Quick Answer: Lyophilized or pasteurized, which is better?

Both forms are safe and studied, and the choice is not as clear-cut as "alive is better." In fact, the strongest human evidence so far is for the pasteurized (heat-treated) form, and in the key mouse study the pasteurized form worked at least as well as, or better than, the live one. Live cells have theoretical advantages, such as producing short-chain fatty acids and interacting with the gut over time, but those advantages have not yet translated into better results in people. So the best choice depends on what you value: proven human data (pasteurized has more of it today), mechanistic potential (live), product stability, and, in the EU, which form is legally authorized (only pasteurized).

Introduction: Why the Form Matters

Akkermansia was first isolated in 2004 and stood out because of where it lives: in the mucus layer of the intestine, at the interface between the body and the gut contents. From that position it interacts with the gut barrier, the immune system, and metabolic signaling, which is why it is often described as a keystone species for gut health. Over the last two decades, its abundance has been linked to lower obesity risk, better insulin sensitivity, and lower inflammation.

As Akkermansia moved into supplements, formulation became the practical question. The same species can be sold live and freeze-dried (lyophilized) or heat-treated (pasteurized), and these forms differ in what they can do in the gut, how stable they are, and how they are regulated. The rest of this article compares them on the evidence rather than on slogans.

Lyophilization: What Freeze-Drying Does (and Does Not) Guarantee

Lyophilization, or freeze-drying, removes water under vacuum so bacteria can be kept in a dormant, shelf-stable state and revived later. Done well, it can preserve viable cells that become active again in the gut.

It is important to be clear about what freeze-drying does not guarantee. On its own, it does not ensure that live cells actually survive to where they matter. Viability depends on the strain, the drying process, encapsulation, oxygen-barrier packaging, storage temperature, and surviving stomach acid. This is why a responsible live product reports viable cells (CFU) at the end of shelf life, not just the count at the time of manufacture. A label that says "lyophilized" or "live" does not by itself mean the product delivers live, active Akkermansia.

Why Pasteurized Akkermansia Became Common

Pasteurization heats the cells until they are no longer alive. It became common for three reasons. First, regulation: the EU authorized pasteurized Akkermansia as a novel food in 2022 (Commission Implementing Regulation 2022/168), based on a 2021 EFSA safety opinion, at up to 3.4 x 10 to the 10 cells per day for adults, on the condition that viable cells stay below the limit of detection (EFSA NDA Panel, 2021). Live Akkermansia is not currently authorized as a novel food in the EU. Second, stability: heat-killed cells are shelf-stable and need no cold chain. Third, and most surprising, the research itself: rather than being a weaker version, the pasteurized form performed at least as well as the live form in the pivotal studies, which the next sections explain.

Mechanisms vs Outcomes: The Key Distinction

It helps to separate two questions: what a form can do in theory (mechanism), and what it has actually been shown to do (outcome).

Mechanistically, live cells can do things dead cells cannot. Living Akkermansia ferments mucin and produces short-chain fatty acids such as acetate and propionate, interacts with other microbes, and can trigger a mucin-renewal cycle that may thicken the gut barrier. On paper, these are real advantages of the live form.

In terms of demonstrated outcomes, though, the picture flips. The heat-stable outer-membrane protein Amuc_1100, which interacts with immune receptors and supports the gut barrier, survives pasteurization, and in head-to-head studies the pasteurized form has matched or outperformed the live form. So the mechanisms favor live, while the measured results, so far, favor pasteurized. Both statements are true, and holding them together is the accurate way to understand this topic.

What Pasteurized Akkermansia Can and Cannot Do

Pasteurized Akkermansia has real limits. Because the cells are not alive, they cannot produce short-chain fatty acids on their own, cannot compete or signal within the microbiome, and cannot drive the mucin-renewal cycle in real time. Those are genuine differences from live cells.

What pasteurized cells are not is inert. The heat-stable Amuc_1100 protein and other cell-wall components still interact with the gut lining and immune receptors, which appears to be a large part of why the pasteurized form has produced measurable metabolic benefits in studies. Describing pasteurized Akkermansia as merely passive fragments is not accurate.

What the Studies Show

In humans. In the first human trial, a 3-month placebo-controlled study in overweight and obese adults with insulin resistance, the pasteurized form significantly improved insulin sensitivity and lowered insulin and total cholesterol, while the live form trended in the same direction but did not reach significance, likely because the study was small (Depommier et al., 2019). A newer and larger 2026 multicenter trial in 142 adults with metabolic syndrome, again using the pasteurized form, did not meet its main insulin-sensitivity goal for the whole group, but found benefits in people who started with low Akkermansia levels and in those with prediabetes, along with increases in the appetite hormone GLP-1 (Suenaert et al., 2026). The human evidence base is built mainly on the pasteurized form, and even there the effects are real but moderate.

In animals. In mice, both forms improve metabolic measures, but the pivotal study found, unexpectedly, that pasteurized Akkermansia reduced fat mass and improved insulin resistance more than the live bacterium, an effect traced largely to the heat-stable Amuc_1100 protein (Plovier et al., 2017). This is the opposite of the common assumption that live must work better.

Live vs Pasteurized at a Glance

How to Choose

• If you want the option with the most human evidence today, that is currently the pasteurized form.

• If you value the theoretical advantages of live cells and accept that superiority is not yet proven, a live (lyophilized) product is a reasonable choice.

• In the EU, only the pasteurized form is authorized as a novel food, which may decide it for you.

• For any live product, look for viable cells (CFU) guaranteed at expiry, sensible encapsulation, and third-party testing. For pasteurized products, check the cell count and that it meets the authorized use levels.

Whatever the form, Akkermansia works best as part of a broader routine of fiber-rich diet, activity, and sleep, not as a stand-alone fix.

Where Next-Microbiome Products Fit

Next-Microbiome offers live formats for people who prefer that approach, including Akkermansia Chewable and Boost Synergy, which combines Akkermansia muciniphila with butyrate-producing Clostridium butyricum and Bifidobacterium infantis (product links). These are live-cell products, chosen for the mechanistic reasons above. As the evidence section makes clear, live formulations are promising but not proven superior to pasteurized ones, so they are best viewed as one option within a broader routine. Some researchers have also suggested that future products could combine pasteurized components with live cells, though that hybrid approach is still theoretical. Check with a clinician if you are pregnant, nursing, managing a condition, or taking medication.

Frequently Asked Questions

1. What is lyophilized Akkermansia?

It is freeze-dried Akkermansia, processed to keep cells in a dormant, potentially viable state that can revive in the gut, provided the product is made and stored to preserve viability.

2. What is pasteurized Akkermansia?

It is heat-treated Akkermansia. The cells are no longer alive, but heat-stable components such as the Amuc_1100 protein remain active and have been studied for metabolic effects.

3. Which form has the stronger human evidence?

Pasteurized. The main human trials used the pasteurized form and showed improvements in metabolic markers; the live form has less human data so far.

4. Does live automatically work better than pasteurized?

No. Live cells have theoretical advantages such as producing short-chain fatty acids, but in the key mouse study and the human trials the pasteurized form performed at least as well. Neither form is established as superior.

5. Is either form stable in supplements?

Pasteurized is very stable. Live products can be shelf-stable when freeze-drying, encapsulation, and packaging are done well, but the "live" label alone does not guarantee viability, so check CFU at expiry.

6. Are they safe?

Both live and pasteurized forms have been well tolerated in clinical trials. Pasteurized Akkermansia is authorized in the EU as a novel food for adults at up to 3.4 x 10 to the 10 cells per day.

7. Which is better for weight or metabolic support? 

Neither is proven superior. The measurable human benefits to date come mainly from the pasteurized form, and the effects are moderate. Either form is best used alongside diet, activity, and sleep.

The Bottom Line

This is not a simple contest between living and dead. Live Akkermansia has genuine mechanistic appeal, including short-chain fatty acid production and gut-barrier renewal, while the pasteurized form has, so far, the stronger human and animal evidence and clear regulatory approval in the EU. Rather than choosing on a "live equals better" slogan, choose based on the evidence you find most convincing, the stability and quality of the specific product, your region's rules, and how it fits a broader healthy routine. As larger trials report, this picture may sharpen. For now, both forms are reasonable, and neither is a proven winner.

Scientific References:

1. Plovier H, Everard A, Druart C, et al.
   A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice
   Nature Medicine 2017;23(1):107-113
   doi:10.1038/nm.4236 (Animal study; pasteurized outperformed live)

2. Depommier C, Everard A, Druart C, et al.
   Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
   Nature Medicine 2019;25(7):1096-1103
   doi:10.1038/s41591-019-0495-2 (Human randomized trial; pasteurized form.)

3. Suenaert P, Segers A, Rymenans L, et al.
   Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome
   Gut Microbes 2026;18(1):2690689
   doi:10.1080/19490976.2026.2690689 (Newer, larger human randomized trial)

4. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA).
   Safety of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283
   EFSA Journal 2021;19(9):6780
   doi:10.2903/j.efsa.2021.6780 (Regulatory safety opinion)

5. Cani PD, Depommier C, Derrien M, Everard A, de Vos WM.
   Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms
   Nature Reviews Gastroenterology and Hepatology 2022;19(10):625-637
   doi:10.1038/s41575-022-00631-9 (Review)

6. Everard A, Belzer C, Geurts L, et al.
   Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
   PNAS 2013;110(22):9066-9071 (Animal study; gut barrier mechanism)

Written by Ali Rıza Akın

Microbiome Scientist, Author & Founder of Next-Microbiome

Ali Rıza Akın is a microbiome scientist with nearly 30 years of experience in translational biotechnology, systems biology, and applied microbiome research, spanning discovery, preclinical development, and clinical-stage translation.

His work focuses on how microbial ecosystems interact with human physiology, including:

• Gut barrier function and intestinal permeability

• Mucus-associated microbiota (Akkermansia-related systems)

• Oral–gut microbiome axis

• Short-chain fatty acids (SCFAs) and metabolic signaling

• Circadian rhythm–microbiome interactions

• Clinical Research Contributions

He has contributed to multiple clinical-stage microbiome programs, supporting bacterial strain discovery, optimization, and formulation design across different therapeutic areas, including:

Active Ulcerative Colitis (Inflammatory Bowel Disease)

Hyperoxaluria (Oxalate Metabolism Disorder)

Microbiome-driven gut health and inflammatory conditions

These studies were part of broader clinical development programs evaluating microbiome-based approaches. His contributions focused on the early-stage scientific and translational pipeline, including strain discovery, functional optimization, and multi-strain formulation design.

Scientific Contributions:

Ali Rıza Akın is the discoverer of Christensenella californii, a bacterial species associated with microbiome diversity and metabolic health.

He is a contributing author to scientific publications and Bacterial Therapy of Cancer (Springer), and the author of Bakterin Kadar Yaşa: İçimizdeki Evren: Mikrobiyotamız.

Approach:

His work emphasizes evidence-based microbiome science, long-term safety, and a systems-based understanding of how microbes influence human health.

Review and Sources

This article is written and reviewed by a microbiome scientist and is based on the peer-reviewed studies and regulatory opinions listed in the References. It is reviewed periodically against current research.

This content is for educational and informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Dietary supplements are not a substitute for prescription medication or professional care. Consult a qualified healthcare professional before making changes to your diet, supplement routine, or treatment, especially if you are pregnant, nursing, managing a health condition, or taking medication.

Last reviewed: July 2026